Skip to main content
Clinical Trials/NCT05377749
NCT05377749
Completed
N/A

Families Addressing Cancer Together (FACT): A Pilot Randomized Trial

UNC Lineberger Comprehensive Cancer Center1 site in 1 country47 target enrollmentJuly 5, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Neoplasms
Sponsor
UNC Lineberger Comprehensive Cancer Center
Enrollment
47
Locations
1
Primary Endpoint
Families Addressing Cancer Together (FACT) Satisfaction Scale
Status
Completed
Last Updated
last year

Overview

Brief Summary

The proposed pilot randomized controlled trial will test the FACT (Families Addressing Cancer Together) intervention designed to improve parents' confidence and ability to talk about their cancer with their minor children. We will enroll 40 patients with cancer who have a minor child to participate in this single site, 6-week study. The primary hypothesis being tested is that an intervention that assists parents with their communication needs with their children can be feasible and acceptable when compared with a wait-list control condition.

Detailed Description

Parents with cancer are encouraged to be "honest and open" with their minor children about their illness. However, many lack access to professional support for their communication needs. Without this support, parents with cancer and their children experience avoidable psychosocial distress. In order to better support parental communication needs in cancer, psychosocial interventions that can be implemented across clinical practice settings are needed. To address this gap, we developed and pilot-tested FACT (Families Addressing Cancer Together) - a theory-guided, web-based psycho-educational intervention to help parents with cancer talk about their illness with their children in a developmentally appropriate way. The proposed pilot randomized controlled trial will test the feasibility and acceptability of the FACT intervention. We will enroll 40 patients with cancer who have a minor child to participate in this single site, 6-week study. The primary hypothesis being tested is that an intervention that assists parents with their communication needs with their children can be feasible and acceptable when compared with a wait-list control condition. We will also explore preliminary effects of the intervention on parental communication and psychological outcomes.

Registry
clinicaltrials.gov
Start Date
July 5, 2022
End Date
February 22, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Informed consent reviewed and signed;
  • Age equal to or above 18 years;
  • Ability to understand and comply with study procedures;
  • Able to complete all study measures and visits in English;
  • Be a parent (defined as biological, adoptive, foster, or step-parent), kin caregiver (defined as a relative or someone with a significant emotional relationship who provides full-time care and nurturing of a child), or legal guardian of a child age 3 to 17 years of age who can speak and understand English;
  • Have a diagnosis of Stage II-IV (or equivalent) invasive solid tumor not in surveillance or survivorship

Exclusion Criteria

  • Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
  • Prior participation in the pilot trial or development and user testing protocol preliminary to this study;
  • No current or expected contact with their child; or
  • Existence of other co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol.

Outcomes

Primary Outcomes

Families Addressing Cancer Together (FACT) Satisfaction Scale

Time Frame: 3 weeks

Acceptability was measured by the FACT satisfaction scale in the intervention group using the study-specific, 6-item FACT satisfaction scale. The total score range is 0-18 with higher scores indicating more satisfaction.

Acceptability as Assessed by a Semi-structured, Post-intervention Interview

Time Frame: 6 weeks

Satisfaction with FACT will be assessed via semi-structured, post-intervention interviews. Regarding n's, these interviews were offered as an optional part of participation among those randomized to the intervention (FACT). 12 participants agreed to participate in the interviews.

Acceptability as Measured by FACT Satisfaction Scale

Time Frame: 6 weeks

Satisfaction with FACT will be measured in the intervention group using the study-specific, 6-item FACT satisfaction scale. Total score range is 0-18 with higher scores indicating more satisfaction.

Secondary Outcomes

  • Recruitment Feasibility as Measured by Rate of Eligible Patients Who Consent to Study Participation(6 weeks)
  • Change From Baseline Communication Self-efficacy Using the CSES(Baseline, 6 weeks)
  • Feasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey(3 weeks)
  • Feasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey Assessments at 6 Weeks.(6 weeks)

Study Sites (1)

Loading locations...

Similar Trials